
    
      The rate of obesity in adults continues to increase. Obesity affects overall health and is
      associated with an increased risk for diabetes, high blood pressure, coronary artery disease,
      osteoarthritis, and sleep apnea. To date, the medication options to treat obesity have been
      limited.

      This study will examine if a new investigational drug, ATHX-105 phosphate, may cause weight
      loss in humans over a 12-week period.
    
  